NCT02027909

Brief Summary

Providing ideal rate response to patients should improve their quality of life and ability to execute activities of daily living. Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to specify an "activities of daily living" (ADL) response rate and an "exertion" response rate. There is much data to support the target heart rate for an exercise response but the data to support the programming of the ADL rate is lacking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

December 31, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 6, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

April 25, 2018

Status Verified

April 1, 2018

Enrollment Period

3.4 years

First QC Date

December 31, 2013

Last Update Submit

April 23, 2018

Conditions

Keywords

Sinus Node Dysfunction

Outcome Measures

Primary Outcomes (1)

  • symptom improvement

    Patient report symptoms by clinician interview and patient symptom questionnaire

    study duration of 9 mths

Secondary Outcomes (1)

  • improvement seen on device interrogations and reported improvement of symptoms

    study duration of 9 mths

Study Arms (3)

Therapy group one

Lower rate of 60 bpm and out of the box rate response settings of an ADL Rate of 95 bpm and rate profile optimization on with the only change being adjusting the activity threshold from med/low to low.

Device: Reprogramming dual chamber pacemaker

Therapy group two

Rate response programming will be determined by an exercise test consisting of a 2 minute hall walk will be performed at the 2 week follow up and set points will be manually adjusted to achieve an ADL rate of 95 bpm. Rate Profile Optimization will be turned off. Activity threshold is programmed to low.

Device: Reprogramming dual chamber pacemaker

Therapy group three

Lower rate of 60 bpm and the ADL rate based upon 220- age x 55%. Activity threshold is programmed to low. Rate Profile Optimization will be turned ON.

Device: Reprogramming dual chamber pacemaker

Interventions

Reprogramming rate response feature in the Medtronic pacemaker to each arm with crossover

Also known as: Medtronic dual chamber pacemaker
Therapy group oneTherapy group threeTherapy group two

Eligibility Criteria

Age60 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

New implantation of a dual chamber pacemaker due to symptomatic sinus dysfunction or chronotropic incompetence defined as exercise heart rate less than 100 beats per minute

You may qualify if:

  • Diagnosis of hypertension
  • Sinus node dysfunction
  • New implantation of a dual chamber pacemaker due to symptomatic sinus dysfunction or chronotropic incompetence defined as exercise heart rate less than 100 beats per minute

You may not qualify if:

  • Second or Third degree AV block
  • Age less than 60 or greater than 95 years
  • EF less than 45%
  • Patients that are not ambulatory
  • Persistent atrial fibrillation (atrial fibrillation lasting greater than 7 days)
  • Permanent atrial fibrillation (atrial fibrillation lasting great than 1 year)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wellmont CVA Heart Institute

Kingsport, Tennessee, 37660, United States

Location

Related Publications (3)

  • Lau CP, Leung SK. Clinical usefulness of rate adaptive pacing systems: what should we assess? Pacing Clin Electrophysiol. 1994 Dec;17(12 Pt 1):2233-5. doi: 10.1111/j.1540-8159.1994.tb02370.x. No abstract available.

    PMID: 7885929BACKGROUND
  • Lau CP, Tai YT, Leung WH, Wong CK, Lee P, Chung FL. Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life. Eur Heart J. 1994 Nov;15(11):1445-55. doi: 10.1093/oxfordjournals.eurheartj.a060413.

    PMID: 7835358BACKGROUND
  • Oto MA, Muderrisoglu H, Ozin MB, Korkmaz ME, Karamehmetoglu A, Oram A, Oram E, Ugurlu S. Quality of life in patients with rate responsive pacemakers: a randomized, cross-over study. Pacing Clin Electrophysiol. 1991 May;14(5 Pt 1):800-6. doi: 10.1111/j.1540-8159.1991.tb04110.x.

    PMID: 1712957BACKGROUND

MeSH Terms

Conditions

Sick Sinus Syndrome

Condition Hierarchy (Ancestors)

Arrhythmia, SinusArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesHeart BlockCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Arun Rao, MD

    Wellmont CVA Heart Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
9 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Arun Rao, MD. FACC

Study Record Dates

First Submitted

December 31, 2013

First Posted

January 6, 2014

Study Start

November 1, 2011

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

April 25, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations